Core Viewpoint - FirstCash Holdings, Inc. has successfully completed the acquisition of H&T Group plc, marking its entry into the European market and enhancing its position as a global leader in the pawn industry with over 3,300 retail locations and annualized pro forma revenues nearing $4 billion [2][4]. Company Overview - FirstCash is a leading international operator of pawn stores, serving cash and credit-constrained consumers with more than 3,300 locations across the U.S., Latin America, and the U.K. [11]. - The company focuses on buying and selling a variety of merchandise and providing small non-recourse pawn loans secured by personal property [11]. Acquisition Details - The acquisition of H&T, the largest pawn store operator in the U.K. with 286 locations, was finalized on August 14, 2025, with H&T shareholders receiving 650 pence per share, totaling an equity value of £289 million (approximately $383 million) [8]. - FirstCash also assumed H&T's net debt of approximately £64 million (around $85 million) [8]. Financial Impact - H&T's stand-alone financial metrics for the full year 2025 are projected to include revenues between $315 million and $340 million, net income of $35 million to $38 million, and EBITDA of $60 million to $65 million [6]. - The expected earnings per share accretion for FirstCash from H&T for the remainder of 2025 is anticipated to be in the range of $0.20 to $0.25 per share [6][7]. Strategic Importance - The acquisition is expected to be immediately accretive to earnings, with strong pawn customer demand and double-digit pawn receivable growth reported by H&T in 2025 [5]. - The combination of FirstCash and H&T is seen as a platform for further international expansion, with H&T's market-leading position providing access to an attractive market [4][5].

Second quarter 2025 GAAP net loss of $(13.2) million or $(0.60) per basic weighted average common share and Distributable Earnings(1) of $3.4 million or $0.15 per basic weighted average common share Announces Intention to Convert from Mortgage REIT to BDC WEST PALM BEACH, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Advanced Flower Capital Inc. (Nasdaq: AFCG) (“Advanced Flower Capital”, “AFC” or the “Company”) today announced its results for the quarter ended June 30, 2025. AFC reported generally accepted accoun ...

Please see the attached notification. Attachment Tilkynning 19. gr. MAR - SÓÓ ...

Phase 3 SELVA trial evaluating QTORIN™ 3.9% rapamycin anhydrous gel (QTORIN™ rapamycin) for microcystic lymphatic malformations completed enrollment, exceeding enrollment target by over 25%; top-line results on track for the first quarter of 2026 Top-line results for Phase 2 TOIVA trial evaluating QTORIN™ rapamycin for cutaneous venous malformations remain on track for the fourth quarter of 2025 QTORIN™ rapamycin has the potential to be the first approved therapy and standard of care in the U.S. for microcy ...

COPENHAGEN, Denmark, August 14, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, provides business update and announces second quarter 2025 financial results. Business highlights (since last quarterly update)Evaxion continues to execute its strategy and plans with a number of significant achievements across the company in recent months. We remain on track to achieve the milestones set for 2025. Highlights include: Con ...

Completed Oversubscribed $8.2 Million Capital Raise; Funded Through At Least Fiscal Year 2026 EDEN PRAIRIE, Minn., Aug. 14, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company dedicated to transforming the surgical diagnosis and treatment of neurological disorders, has reported financial results for the third quarter of fiscal year 2025 ended June 30, 2025. Recent Company Highlights Product revenue increased 105% to $1 ...

Core Insights - Xilio Therapeutics announced updated Phase 2 data for vilastobart, showing deep and durable responses with a differentiated safety profile for anti-CTLA-4 combination therapy [1][5] - The company is on track to nominate its first development candidates for masked T cell engager programs in the second half of 2025 [1][12] - As of June 30, 2025, Xilio reported $121.6 million in cash and cash equivalents, providing a cash runway through the end of the third quarter of 2026 [1][13] Pipeline and Business Updates - Vilastobart is a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody currently evaluated in combination with atezolizumab for advanced solid tumors and metastatic microsatellite stable colorectal cancer [3][14] - XTX301, a tumor-activated IL-12, is designed to stimulate anti-tumor immunity and is being evaluated as a monotherapy in a Phase 1 clinical trial [4][15] - Xilio's masked T cell engager programs include bispecific and tri-specific molecules designed to enhance T cell activation and are advancing through IND-enabling studies [7][9] Financial Results - Collaboration and license revenue for the quarter ended June 30, 2025, was $8.1 million, up from $2.4 million in the same quarter of 2024 [17] - Research and development expenses increased to $15.3 million in Q2 2025 from $11.2 million in Q2 2024, driven by clinical development activities [17] - The net loss for the quarter ended June 30, 2025, was $15.8 million, compared to a net loss of $13.9 million for the same period in 2024 [17][23]

WILMINGTON, N.C., Aug. 14, 2025 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, will report financial results for its second quarter ended July 31, 2025, after the market close on Tuesday, August 26, 2025. nCino will host a conference call and webcast that day at 4:30 p.m. ET to discuss its financial results. Event: nCino’s Second Quarter Fiscal Year 2026 Financial Results Conference CallDate and Time: Tuesday, August 26, 2025 at 4:30 p.m ...

Company Continues its Expansion with a New Prime Studio Location and Experienced Team in Dallas Fort Worth’s Lakewood Area NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Boston, MA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- MiniLuxe Holding Corp. (TSXV: MNLX) (“MiniLuxe” or the “Company”) is pleased to announce that, further to its press release dated August 11, 2025, it has completed (with the approval of the TSXV) the issuance a total of 437,500 Class A subord ...

Builds on Prior SmartGateway Installation as Customer Site ExpandsTORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”) today announced it has been awarded a US$2.6 million contract to expand its SmartGateway deployment at a major international entertainment organization’s venue. This additional project extends Xtract One’s 2023 installation at the same location and demonstrates customer satisfaction along with growing demand f ...